An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Conclude your understanding of lymphoma with an in-depth look at its signs and symptoms, from common indicators to subtle clues.

Speaker : Dr Suvir Singh

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

Expert panel discussion on on the use of palbociclib in endocrine-resistant breast cancer. Learn about the clinical trial and optimize treatment strategies.

Speakers : Dr. Srinivas K G , Dr. Abhaya Kumar S M ,Dr. Vishwanath S

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

Join Dr. Srinivas K G, Dr. Abhaya Kumar S M, and Dr. Vishwanath S in a panel discussion on clinical trial endpoints for tumors with PPS > 12 months.

Speakers : Dr. Srinivas K G , Dr. Abhaya Kumar SM , Dr. Vishwanath S

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

Discover real-world clinical outcomes, key findings, and expert insights for optimizing patient care. Watch now for evidence-based oncology perspectives!

Speakers : Dr. Srinivas K G

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

Explore how CDK4/6 inhibitors are transforming HR+/HER2- advanced breast cancer treatment in post-menopausal women.

Speakers : Dr. Srinivas K G , Dr. Abhaya Kumar S M

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

Discover how CDK4/6 inhibitors revolutionized HR+/HER2- metastatic breast cancer treatment in this expert analysis of the PALOMA-2 trial by Dr. Srinivas K G.

Speakers : Dr. Srinivas K G

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions

Explore expert insights from Dr. Pawan Kumar Singh, Dr. Roshan Dikshit, Dr. Manisha Jain, and Dr. Avriti Baveja on the latest treatment strategies for relapsed/refractory adult B-cell ALL.

Speakers : Dr. Pawan Kumar Singh ,Dr. Roshan Dixit ,Dr. Manisha Jain ,Dr. Avruti Baweja

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

Explore expert insights from Dr. Pawan Kumar Singh, Dr. Roshan Dikshit, Dr. Manisha Jain, and Dr. Avriti Baveja on the cost and hospitalization burden for R/R ALL patients.

Speakers : Dr. Pawan Kumar Singh , Dr. Manisha Jain , Dr. Roshan Dikshit , Dr. Avriti Baveja

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

Explore the long-term survival outcomes of iontuzumab-treated patients in the INO-VATE trial with experts Dr. Pawan Kumar Singh, Dr. Roshan Dikshit, Dr. Manisha Jain, and Dr. Avriti Baveja.

Speakers : Dr. Pawan Kumar Singh , Dr. Manisha Jain , Dr. Roshan Dikshit , Dr. Avriti Baveja

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

Explore expert insights from Dr. Pawan Kumar Singh, Dr. Roshan Dikshit, Dr. Manisha Jain, and Dr. Avriti Baveja on Iontuzumab’s impact on CR/CRi rates and MRD negativity in leukemia.

Speakers : Dr. Pawan Kumar Singh , Dr. Manisha Jain , Dr. Roshan Dikshit , Dr. Roshan Dikshit , Dr. Avriti Baveja

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

Learn about CAR T-cell therapy, bispecific antibodies, and personalized treatment strategies. Watch now for cutting-edge recommendations!

Speakers : Dr. Pawan Kumar Singh , Dr. Manisha Jain , Dr. Roshan Dikshit , Dr. Avriti Baveja


Recommended News For You

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type

The Early Progression of Prostate Cancer Is Not Stopped by Metformin.

Is Laughter Good for Blood Glucose Control?

Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?

Doctors say lung cancer is still the deadliest cancer, but hope is growing

Poor agreement between diagnostic tests for breast cancer-related lymphedema

Recommended Articles For You

Adaptive Immune Reprogramming in Advanced Solid Tumors 

A New Hope: How Procarbazine is Revolutionizing Cancer Treatment 

The latest Hematocrit: An Overview of Red Blood Cell Health  

Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer 
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment

2.

A small rise in cancer was observed following the 1986 Chernobyl accident.

3.

First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.

4.

New research uncovers link between cancer pathway and blood-retina barrier function

5.

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases

1.

Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians

2.

Survivorship Planning Beyond Active Cancer Care

3.

Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options

4.

Integrated Models in Hematology for Specialists

5.

Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

3.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

4.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

5.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot